Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 1485  

    Article Cited by others


Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature

Nadebaum David P, Lee Sze Ting, Nikfarjam Mehrdad, Scott Andrew M

Year : 2018| Volume: 17| Issue : 3 | Page no: 195-197

   This article has been cited by
1 Added value of [68Ga]Ga-DOTA-TOC PET/CT for characterizing pancreatic neuroendocrine neoplasms: a comparison with contrast-enhanced CT and/or MRI in a large study cohort
Jeongin Yoo,Se Hyung Kim,Sun Kyung Jeon,Jae Seok Bae,Joon Koo Han
European Radiology. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors
Catherine Ansquer,Yann Touchefeu,Alain Faivre-Chauvet,Christophe Leux,Maëlle Le Bras,Nicolas Régenet,Vincent Fleury,Bruno Maucherat,Hélène Senellart,Serge Guyetant,Thomas Carlier,Evelyne Scotet-Cérato,Aurore Rauscher,Eric Frampas,Françoise Kraeber-Bodéré
Clinical Nuclear Medicine. 2021; 46(3): 181
[Pubmed]  [Google Scholar] [DOI]
3 Clinical utility of 68Ga-DOTATOC positron emission tomography/computed tomography for recurrent renal cell carcinoma
Yuji Nakamoto,Takayoshi Ishimori,Yoichi Shimizu,Kohei Sano,Kaori Togashi
European Journal of Nuclear Medicine and Molecular Imaging. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article